Surveillance study following the completion of "Peretinoin Phase2/3 study"
Not Applicable
- Conditions
- hepatocellular carcinoma with HCV-RNA positive
- Registration Number
- JPRN-UMIN000006728
- Lead Sponsor
- Social insurance Alliance Shimonoseki Kohsei Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 392
Inclusion Criteria
Not provided
Exclusion Criteria
"HBs" positive patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall Survival
- Secondary Outcome Measures
Name Time Method